Trial Profile
A Rising-Single-Dose and Multiple-Dose Safety, Tolerability, and Pharmacokinetic Study of SCH 900117 in Healthy Volunteers and in Subjects with Rheumatoid Arthritis.
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs SCH 900117 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Schering-Plough
- 24 Mar 2009 New trial record